↓ Skip to main content

Cannabinoids for Cancer Treatment: Progress and Promise: Figure 1.

Overview of attention for article published in Cancer Research, January 2008
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#34 of 16,928)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

blogs
3 blogs
twitter
115 tweeters
facebook
779 Facebook pages
googleplus
35 Google+ users
reddit
3 Redditors
video
2 video uploaders

Citations

dimensions_citation
191 Dimensions

Readers on

mendeley
280 Mendeley
citeulike
2 CiteULike
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabinoids for Cancer Treatment: Progress and Promise: Figure 1.
Published in
Cancer Research, January 2008
DOI 10.1158/0008-5472.can-07-2785
Pubmed ID
Authors

Sami Sarfaraz, Vaqar M. Adhami, Deeba N. Syed, Farrukh Afaq, Hasan Mukhtar

Abstract

Cannabinoids are a class of pharmacologic compounds that offer potential applications as antitumor drugs, based on the ability of some members of this class to limit inflammation, cell proliferation, and cell survival. In particular, emerging evidence suggests that agonists of cannabinoid receptors expressed by tumor cells may offer a novel strategy to treat cancer. Here, we review recent work that raises interest in the development and exploration of potent, nontoxic, and nonhabit forming cannabinoids for cancer therapy.

Twitter Demographics

The data shown below were collected from the profiles of 115 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 280 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 7 3%
United Kingdom 2 <1%
Uruguay 1 <1%
Unknown 270 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 47 17%
Researcher 45 16%
Student > Ph. D. Student 42 15%
Student > Master 41 15%
Student > Postgraduate 19 7%
Other 51 18%
Unknown 35 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 54 19%
Biochemistry, Genetics and Molecular Biology 52 19%
Medicine and Dentistry 48 17%
Chemistry 16 6%
Pharmacology, Toxicology and Pharmaceutical Science 15 5%
Other 51 18%
Unknown 44 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 355. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2022.
All research outputs
#63,828
of 21,229,756 outputs
Outputs from Cancer Research
#34
of 16,928 outputs
Outputs of similar age
#183
of 107,055 outputs
Outputs of similar age from Cancer Research
#2
of 133 outputs
Altmetric has tracked 21,229,756 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,928 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,055 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 133 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.